0 NASDAQ Companies - July 29, 2019Arvinas Appoints Ronald Peck, M.D. as Chief Medical OfficerRead More
0 NASDAQ Companies - July 29, 2019Capital City Bank Group Board of Directors Announces New MemberRead More
0 NASDAQ Companies - July 29, 2019Avadel Pharmaceuticals to Report Second Quarter 2019 Financial ResultsRead More
0 NASDAQ Companies - July 29, 2019Akcea Therapeutics to Hold Second Quarter 2019 Financial Results WebcastRead More
0 NASDAQ Companies - July 29, 2019Amicus Therapeutics to Announce Second Quarter 2019 Financial Results on August 8, 2019Read More
0 NASDAQ Companies - July 29, 2019European Medicines Agency Grants PRIME Access to ProQR’s Sepofarsen for Leber’s Congenital Amaurosis 10Read More
0 NASDAQ Companies - July 29, 2019Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal RezafunginRead More
0 NASDAQ Companies - July 29, 2019Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich SyndromeRead More
0 NASDAQ Companies - July 29, 2019Axogen, Inc. to Participate at Canaccord Genuity 39th Annual Growth ConferenceRead More
